MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2017 International Congress

June 4-8, 2017. Vancouver, BC.

View by Title View Sessions
View by Date
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • The Putamen to Caudate Nucleus Ratio: A Simple Surrogate Marker for Dopaminergic Volume in Putamen

    J.J. Lee, Y.H. Sohn (Goyang-si, Republic of Korea)

  • The Relationship between Olfactory Function and Clinical Subtypes of Parkinson’s Disease

    D.-Y. Kwon (Ansan, Republic of Korea)

  • The Relative Preservation of the Dopaminergic Neuroal Loss of Patients with Parkinson’s Disease Having Dopamine-Unresponsive Resting Tremor

    S. You, H.W. Kim (Daegu, Republic of Korea)

  • The Role of Clinical Outcome Assessment (COA) Data in the Drug Approval Process of Medicines for the Treatment of Restless Legs Syndrome (RLS): A Review of the Labels of Medicines Approved by the FDA and the EMA

    M.-P. Emery, C. Anfray, L.-L. Perrier, C. Acquadro (Lyon, France)

  • The role of habenula and amygdala dysfunction in Parkinson’s disease patients with punding

    V. Markovic, F. Agosta, E. Canu, A. Inuggi, I. Petrovic, I. Stankovic, F. Imperiale, T. Stojkovic, V. Kostic, M. Filippi (Belgrade, Serbia)

  • The Role of MRI and DaTscan in Vascular Parkinsonism: A Case Report

    A. Tran, M. Amin, R. Burns (Phoenix, AZ, USA)

  • The role of phosphodiesterase 4 in sleep disturbances in Parkinson’s disease

    H. Wilson, G. Pagano, F. Niccolini, N. Muhlert, C. Coello, M. Mehta, G. Searle, R. Gunn, E. Rabiner, T. Foltynie, M. Politis (London, United Kingdom)

  • The Role of Social Work in Improving Comprehensive Care for Parkinson’s Disease

    E. Book, A. Lemen (Vancouver, BC, Canada)

  • The Roles of Diet, Exercise, & Supplements in Parkinson’s Disease Progression

    L. Mischley, R. Lau (Kenmore, WA, USA)

  • The secular change of quality of life in patients with Parkinson’s disease.

    A. Kumon, M. Saruwatari, N. Kawashima, K. Hasegawa (Sagamihara, Japan)

  • « Previous Page
  • 1
  • …
  • 140
  • 141
  • 142
  • 143
  • 144
  • …
  • 155
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • #22901 (not found)
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • An atypical and interesting feature of Parkinson´s disease
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley